|Andy Boyer, GGM North America President & CEO Speaks on Association for Accessible Medicines (AAM) Industry-CEO Panel|
Today Andrew Boyer, Teva's President & CEO of Global Generic Medicines, North America spoke on a panel of industry CEOs during the annual meeting of the Association for Accessible Medicines (AAM). The AAM, formerly known as the Generic Pharmaceutical Association (GPhA), hosted leadership from Teva, Momenta Pharmaceuticals, Lupin Limited and Dr. Reddy's Laboratories during the “CEO Unplugged” panel moderated by ABC News reporter John Donvan. Andy highlighted the importance of the generic pharmaceutical industry in the larger context of U.S. healthcare, and the importance of sharing our story of value and access to American patients.
"We must continue collaborating within our industry to better explain generic medicines' impact and how our market works to stakeholders and legislators," Boyer noted during the AAM panel. "There is some very real confusion about how the generic pharmaceutical industry works, how generic medicines are made, how they're priced, and how our products impact the healthcare system as a whole. The U.S. healthcare system simply doesn't work without generic products; so it's an exciting time to be part of telling our story."
Boyer concluded, "At this year's meeting, GPhA formally became the Association for Accessible Medicines, and it's an important rebrand for our industry. I encourage Teva employees to engage with AAM's new brand identity; it's a strong step in the right direction and a good example of how we need to tell our story to a larger audience."